Procyon Diagnostics
PrivateLast Round
Pre Seed
Oct 22, 2025
Company Overview
Procyon Diagnostics is a biotechnology company that develops non-invasive diagnostic tests for early cancer detection using biomarker technology and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
precision oncologycancer diagnosticsbiomarker technologyliquid biopsyearly cancer detectiondiagnostic assaymedical AIpancreatic cancer screeningnon-invasive testingclinical diagnosticsAI diagnosticsbiotech spin-outELISArisk stratificationdigital health
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Procyon Diagnostics Comparables
Compare Procyon Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xgenera | 83% | |
| Immunovia AB (publ) | 78% | |
| Mursla Bio | 77% | |
Procyon Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 22, 2025 |
Procyon Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Procyon Diagnostics's valuation, stock price, and market status.